Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses

Author:

Vecchio FedericaORCID,Carré AlexiaORCID,Korenkov Daniil,Zhou Zhicheng,Apaolaza Paola,Tuomela Soile,Burgos-Morales Orlando,Snowhite Isaac,Perez-Hernandez Javier,Brandao Barbara,Afonso Georgia,Halliez Clémentine,Kaddis John,Kent Sally C.ORCID,Nakayama MakiORCID,Richardson Sarah J.ORCID,Vinh Joelle,Verdier Yann,Laiho Jutta,Scharfmann Raphael,Solimena Michele,Marinicova Zuzana,Bismuth Elise,Lucidarme Nadine,Sanchez Janine,Bustamante Carmen,Gomez Patricia,Buus Soren,You SylvaineORCID,Pugliese AlbertoORCID,Hyoty HeikkiORCID,Rodriguez-Calvo TeresaORCID,Flodstrom-Tullberg MalinORCID,Mallone RobertoORCID,

Abstract

SummaryCoxsackievirus B (CVB) infection of pancreatic β cells is associated with β-cell autoimmunity. We investigated how CVB impacts human β cells and anti-CVB T-cell responses. β cells were efficiently infected by CVBin vitro, downregulated HLA Class I and presented few, selected HLA-bound viral peptides. Circulating CD8+T cells from CVB-seropositive individuals recognized only a fraction of these peptides, and only another sub-fraction was targeted by effector/memory T cells that expressed the exhaustion marker PD-1. T cells recognizing a CVB epitope cross-reacted with the β-cell antigen GAD. Infected β cells, which formed filopodia to propagate infection, were more efficiently killed by CVB than by CVB-reactive T cells. Thus, ourin-vitroandex-vivodata highlight limited T-cell responses to CVB, supporting the rationale for CVB vaccination trials for type 1 diabetes prevention. CD8+T cells recognizing structural and non-structural CVB epitopes provide biomarkers to differentially follow response to infection and vaccination.

Publisher

Cold Spring Harbor Laboratory

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3